Table 2

Candidate gene identification outside hotspot loci

Nominally associated genesChrStartEndPatients (n=2454)Controls (n=6746)Nominal p valueConstrained gene*
RBFOX1166 069 1317 763 3403 (AFE, AFE, GGE)00.019No
NRXN1250 145 64251 259 6743 (GGE, GGE, RE)00.019No
Candidate genes
 LOC102723362222 759 35022 761 1592 (GGE, RE)00.0711Yes
 PCDH7430 722 03631 148 4232 (AFE, GGE)00.0711No
 PACRG6163 148 164163 736 5242 (GGE, AFE)00.0711Yes
 ADGRB1, TSNARE1, LINC00051, MIR1302-7, MIR4472-1, MIR45398142 867 603143 626 3682 (GGE, GGE)00.0711No, No, Yes, Yes, Yes, No
 LOC1019281371273 552 96973 602 0972 (GGE, GGE)00.0711Yes
DDG2P genes
 SKI, DVL111 270 6582 241 6521 (AFE)00.267Yes, No
 KCNA21111 136 202111 174 0961 (GGE)00.267Yes
 GCH11455 308 72455 369 5421 (RE)00.267No
  • *Constrained gene according to the CNV map of healthy individuals.10

  • AFE, adult focal epilepsy; GGE, genetic generalised epilepsy; RE, rolandic epilepsy.

  • Single gene and candidate gene enrichment analysis. Associated genes: genes identified due to nominal enrichment in patients. Candidate genes: epilepsy candidate genes deleted at least twice in patients and not deleted in the control cohort.